Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -110.81% is 30% below its 5-year average of -85.16%, around the middle of its 5-year range (-179.65%–-53.23%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.70% above its 12-month average of -111.59%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -110.81%.
RETURN ON INVESTED CAPITAL (ROIC)
-110.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-111.59%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-81.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-85.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-91.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+0.70%
CURRENT VS 3Y AVG
-36.61%
CURRENT VS 5Y AVG
-30.11%
CURRENT VS 10Y AVG
-20.62%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.87%
median of 701 covered companies
CURRENT VS SECTOR MEDIAN
-227.16%
vs the sector median at left
Jaguar Health, Inc.
Market Cap
$2.55M
Return on Invested Capital (ROIC)
-110.81%
TTM Avg
-111.59%
3Y Avg
-81.11%
5Y Avg
-85.16%
Market Cap
$2.57M
Return on Invested Capital (ROIC)
-237.93%
TTM Avg
-187.67%
3Y Avg
-136.08%
5Y Avg
-136.08%
Market Cap
$2.59M
Return on Invested Capital (ROIC)
-238.32%
TTM Avg
-241.12%
3Y Avg
-206.72%
5Y Avg
-167.10%
Market Cap
$2.47M
Return on Invested Capital (ROIC)
-286.46%
TTM Avg
-159.21%
3Y Avg
-198.72%
5Y Avg
-198.72%
Market Cap
$2.64M
Return on Invested Capital (ROIC)
-476.39%
TTM Avg
-313.80%
3Y Avg
-198.00%
5Y Avg
-161.97%
Market Cap
$2.43M
Return on Invested Capital (ROIC)
-242.25%
TTM Avg
-196.63%
3Y Avg
-136.47%
5Y Avg
-108.21%
Market Cap
$2.37M
Return on Invested Capital (ROIC)
-59.84%
TTM Avg
-167.05%
3Y Avg
-109.85%
5Y Avg
-118.30%
Market Cap
$2.39M
Return on Invested Capital (ROIC)
-71.90%
TTM Avg
-86.03%
3Y Avg
-72.74%
5Y Avg
-64.31%
Market Cap
$2.30M
Return on Invested Capital (ROIC)
-985.20%
TTM Avg
-494.63%
3Y Avg
-376.51%
5Y Avg
-304.92%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jaguar Health, Inc. (JAGX) | $2.55M | -110.81% | -111.59% | -81.11% | -85.16% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.57M | -237.93% | -187.67% | -136.08% | -136.08% |
| Nuwellis, Inc. (NUWE)vs › | $2.59M | -238.32% | -241.12% | -206.72% | -167.10% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | -286.46% | -159.21% | -198.72% | -198.72% |
| iSpecimen Inc. (ISPC)vs › | $2.64M | -476.39% | -313.80% | -198.00% | -161.97% |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.43M | -242.25% | -196.63% | -136.47% | -108.21% |
| Onconetix, Inc. (ONCO)vs › | $2.37M | -59.84% | -167.05% | -109.85% | -118.30% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.39M | -71.90% | -86.03% | -72.74% | -64.31% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.30M | -985.20% | -494.63% | -376.51% | -304.92% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.00M | -75.31% | -107.77% | -224.28% | -195.58% |
ROIC
-110.8%
ROE
-554.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -110.81% |
| 2026-03-31 | -90.14% |
| 2025-12-31 | -179.65% |
| 2025-09-30 | -90.03% |
| 2025-06-30 | -87.31% |
| 2025-03-31 | -76.48% |
| 2024-12-31 | -67.38% |
| 2024-09-30 | -60.37% |
| 2024-06-30 | -59.42% |
| 2024-03-31 | -68.09% |
| 2023-12-31 | -81.66% |
| 2023-09-30 | -90.63% |
| 2023-06-30 | -91.03% |
| 2023-03-31 | -78.42% |
| 2022-12-31 | -104.30% |
| 2022-09-30 | -106.72% |
| 2022-06-30 | -109.22% |
| 2022-03-31 | -107.33% |
| 2021-12-31 | -99.31% |
| 2021-09-30 | -71.39% |
| 2021-06-30 | -53.23% |
| 2021-03-31 | -48.23% |
| 2020-12-31 | -79.75% |
| 2020-09-30 | -158.31% |
| 2020-06-30 | -131.56% |
| 2020-03-31 | -127.70% |
| 2019-12-31 | -104.14% |
| 2019-09-30 | -130.22% |
| 2019-06-30 | -182.17% |
| 2019-03-31 | -109.11% |
| 2018-12-31 | -101.17% |
| 2018-09-30 | -110.74% |
| 2018-06-30 | -104.66% |
| 2018-03-31 | -78.49% |
| 2017-12-31 | -101.73% |
| 2017-09-30 | -34.47% |
| 2016-12-31 | -943.49% |
| 2016-09-30 | -352.79% |
| 2016-06-30 | -233.11% |
| 2016-03-31 | -127.47% |
| 2015-12-31 | -120.18% |
| 2015-09-30 | -72.39% |
| 2015-06-30 | -91.42% |
| 2014-12-31 | -219.53% |
